<DOC>
	<DOCNO>NCT00437294</DOCNO>
	<brief_summary>The purpose study determine whether combination enzastaurin capecitabine effective combination placebo capecitabine treat patient breast cancer previously treat anthracycline taxane .</brief_summary>
	<brief_title>Enzastaurin Combination Capecitabine Treat Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Have diagnose metastatic recurrent breast cancer . Have previously treat anthracycline taxane . Have receive two prior chemotherapy treatment program . Have stop antitumoral hormonal treatment enroll study . Have negative pregnancy blood test menstruating capable become pregnant . You must use approved birth control method study 3 month stop study treatment . Can follow study procedure ( example , swallow tablet ) Are receive another treatment cancer . Have receive another experimental drug last 4 week . Have serious heart disease within last 6 month . Are pregnant breastfeeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>